Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype

被引:81
作者
Robarge, MJ
Husbands, SM
Kieltyka, A
Brodbeck, R
Thurkauf, A
Newman, AH [1 ]
机构
[1] Neurogen Corp, Branford, CT 06405 USA
[2] NIDA, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA
关键词
D O I
10.1021/jm010146o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The dopamine D-3 receptor subtype has been recently targeted as a potential neurochemical modulator of the behavioral actions of psychomotor stimulants, such as cocaine. However, definitive behavioral investigations have been hampered by the lack of highly selective D-3 agonists and antagonists. In an attempt to design a novel class of D-3 ligands with which to study this receptor system, a series of chemically divergent compounds that possessed various structural features that exist within several classes of reputed D-3 agents was screened and compared to the recently reported NGB 2904 (58b). On the basis of these results, a novel series of compounds was designed that included functional moieties that were required for high-affinity and selective binding to D-3 receptors. All the compounds in this series included an aryl-substituted piperazine ring, a varying alkyl chain linker (C3-C5), and a terminal aryl amide. The compounds were synthesized and evaluated in vitro for binding in CHO cells transfected with human D-2, D-3, or D-4 receptor cDNAs. D-3 binding affinities ranged from K-i = 1.4 to 1460 nM. The most potent analogue in this series, 51, demonstrated a D-3/D-2 selectivity of 64 and a D-3/D-4 selectivity of 1300. Structure-activity relationships for this class of ligands at D-3 receptors will provide new leads toward the development of highly selective and potent molecular probes that will prove useful in the elucidation of the role D-3 receptors play in the psychomotor stimulant and reinforcing properties of cocaine.
引用
收藏
页码:3175 / 3186
页数:12
相关论文
共 46 条
[11]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[12]  
CUSSAC D, 2000, ABSTR SOC NEUROSCI, P2154
[13]   BW234U, (CIS-9-[3-(3,5-DIMETHYL-1-PIPERAZINYL)PROPYL]CARBAZOLE DIHYDROCHLORIDE) - A NOVEL ANTIPSYCHOTIC AGENT [J].
FERRIS, RM ;
HARFENIST, M ;
MCKENZIE, GM ;
COOPER, B ;
SOROKO, FE ;
MAXWELL, RA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (06) :388-390
[14]   EVIDENCE THAT THE POTENTIAL ANTIPSYCHOTIC AGENT RIMCAZOLE (BW U-234) IS A SPECIFIC, COMPETITIVE ANTAGONIST OF SIGMA-SITES IN BRAIN [J].
FERRIS, RM ;
TANG, FLM ;
CHANG, KJ ;
RUSSELL, A .
LIFE SCIENCES, 1986, 38 (25) :2329-2337
[15]  
HUANG Y, 2000, ABSTR SOC NEUROSCI, P2154
[16]   Structure-activity relationships at the monoamine transporters and σ receptors for a novel series of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)-propyl]carbazole (rimcazole) analogues [J].
Husbands, SM ;
Izenwasser, S ;
Kopajtic, T ;
Bowen, WD ;
Vilner, BJ ;
Katz, JL ;
Newman, AH .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (21) :4446-4455
[17]   THE DOPAMINE HYPOTHESIS OF THE REINFORCING PROPERTIES OF COCAINE [J].
KUHAR, MJ ;
RITZ, MC ;
BOJA, JW .
TRENDS IN NEUROSCIENCES, 1991, 14 (07) :299-302
[18]   Dopamine D3 receptor agents as potential new medications for drug addiction [J].
Le Foll, B ;
Schwartz, JC ;
Sokoloff, P .
EUROPEAN PSYCHIATRY, 2000, 15 (02) :140-146
[19]   Dopamine D3 receptors -: Relevance for the drug treatment of Parkinson's disease [J].
Levant, B ;
Ling, ZD ;
Carvey, PM .
CNS DRUGS, 1999, 12 (05) :391-402
[20]  
Levant B, 1997, PHARMACOL REV, V49, P231